Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1989 5
1990 7
1991 6
1992 3
1993 5
1994 5
1995 5
1996 4
1997 2
1998 2
1999 5
2000 2
2001 1
2002 2
2004 2
2005 2
2006 1
2007 4
2008 3
2009 4
2010 4
2011 4
2012 1
2014 2
2015 9
2016 6
2017 6
2018 3
2019 5
2020 11
2021 8
2022 3
2023 6
2024 6
2025 9
2026 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

145 results

Results by year

Filters applied: . Clear all
Page 1
An expert discussion on the atypical hemolytic uremic syndrome nomenclature-identifying a road map to precision: a report of a National Kidney Foundation Working Group.
Nester CM, Feldman DL, Burwick R, Cataland S, Chaturvedi S, Cook HT, Cuker A, Dixon BP, Fakhouri F, Hingorani SR, Java A, van de Kar NCAJ, Kavanagh D, Leung N, Licht C, Noris M, O'Shaughnessy MM, Parikh SV, Peyandi F, Remuzzi G, Smith RJH, Sperati CJ, Waldman M, Walker P, Vivarelli M. Nester CM, et al. Kidney Int. 2024 Sep;106(3):326-336. doi: 10.1016/j.kint.2024.05.021. Kidney Int. 2024. PMID: 39174192 Free article.
Pediatric Coagulation Disorders.
Rodriguez V, Warad D. Rodriguez V, et al. Pediatr Rev. 2016 Jul;37(7):279-91. doi: 10.1542/pir.2015-0062. Pediatr Rev. 2016. PMID: 27368359 Review. No abstract available.
Diagnosis and Risk Stratification in Waldenström Macroglobulinemia.
Zanwar S, Kapoor P. Zanwar S, et al. J Natl Compr Canc Netw. 2024 Sep;22(7):e247024. doi: 10.6004/jnccn.2024.7024. J Natl Compr Canc Netw. 2024. PMID: 39236757 Review.
The clinical presentation of WM is variable, ranging from gradually progressive cytopenias, organomegaly, fatigue, B symptoms, and peripheral neuropathy to the more emergent presentation with symptomatic hyperviscosity, cryoglobulinemia, hemolytic anemia-associated symptoms, acqu …
The clinical presentation of WM is variable, ranging from gradually progressive cytopenias, organomegaly, fatigue, B symptoms, and periphera …
The seasonal distribution of immune thrombotic thrombocytopenic purpura is influenced by geography: Epidemiologic findings from a multi-center analysis of 719 disease episodes.
Jacobs JW, Stanek CG, Booth GS, Symeonidis A, Shih AW, Allen ES, Gavriilaki E, Grossman BJ, Pavenski K, Moorehead A, Peyvandi F, Agosti P, Mancini I, Stephens LD, Raval JS, Mingot-Castellano ME, Crowe EP, Daou L, Pai M, Arnold DM, Marques MB, Henrie R, Smith TW, Sreenivasan G, Siniard RC, Wallace LR, Yamada C, Duque MA, Wu Y, Harrington TJ, Byrnes DM, Bitsani A, Davis AK, Robinson DH, Eichbaum Q, Figueroa Villalba CA, Juskewitch JE, Kaiafa G, Kapsali E, Klapper E, Perez-Alvarez I, Klein MS, Kotsiou N, Lalayanni C, Mandala E, Aldarweesh F, Alkhateb R, Fortuny L, Mellios Z, Papalexandri A, Parsons MG, Schlueter AJ, Tormey CA, Wellard C, Wood EM, Jia S, Wheeler AP, Powers AA, Webb CB, Yates SG, Bouzid R, Coppo P, Bloch EM, Adkins BD. Jacobs JW, et al. Am J Hematol. 2024 Nov;99(11):2063-2074. doi: 10.1002/ajh.27458. Epub 2024 Aug 13. Am J Hematol. 2024. PMID: 39136282 Free article.
Laboratory testing in hemophilia: Impact of factor and non-factor replacement therapy on coagulation assays.
Peyvandi F, Kenet G, Pekrul I, Pruthi RK, Ramge P, Spannagl M. Peyvandi F, et al. J Thromb Haemost. 2020 Jun;18(6):1242-1255. doi: 10.1111/jth.14784. Epub 2020 Apr 23. J Thromb Haemost. 2020. PMID: 32115865 Free article. Review.
However, increasing use of these therapies poses challenges to clinicians and coagulation laboratories due to the lack of standardized assays for monitoring of hemostatic parameters, and the potential for misinterpretation of test results, which may jeopardize patient safety. Def …
However, increasing use of these therapies poses challenges to clinicians and coagulation laboratories due to the lack of standardized assay …
Hemophilia: a practical approach to genetic testing.
Pruthi RK. Pruthi RK. Mayo Clin Proc. 2005 Nov;80(11):1485-99. doi: 10.4065/80.11.1485. Mayo Clin Proc. 2005. PMID: 16295028 Review.
Hemophilia and von Willebrand disease together account for the large majority of congenital bleeding disorders. ...This article provides a practical approach to using genetic testing for hemophilia A and B....
Hemophilia and von Willebrand disease together account for the large majority of congenital bleeding disorders. ...This article provi …
The Use of Bypassing Treatment Strategies in Hemophilia and Their Effect on Laboratory Testing.
Pruthi RK, Chen D. Pruthi RK, et al. Semin Thromb Hemost. 2023 Sep;49(6):651-660. doi: 10.1055/s-0043-1768660. Epub 2023 May 5. Semin Thromb Hemost. 2023. PMID: 37146647 Review.
Factor VIII and IX inhibitors in congenital hemophilia A and B, respectively, neutralize the infused coagulation factor concentrate rendering them ineffective. ...Activated prothrombin complex concentrate was the original BPA, recombinant activated factor VII was th …
Factor VIII and IX inhibitors in congenital hemophilia A and B, respectively, neutralize the infused coagulation factor concen …
Commentary.
Nichols WL. Nichols WL. Clin Chem. 2015 Jul;61(7):913. doi: 10.1373/clinchem.2014.232819. Clin Chem. 2015. PMID: 26116640 No abstract available.
GAS6/TAM Pathway Signaling in Hemostasis and Thrombosis.
Law LA, Graham DK, Di Paola J, Branchford BR. Law LA, et al. Front Med (Lausanne). 2018 May 9;5:137. doi: 10.3389/fmed.2018.00137. eCollection 2018. Front Med (Lausanne). 2018. PMID: 29868590 Free PMC article. Review.
145 results